TNFAIP6, an independent prognostic monitor and therapy target, promoted low-grade glioma recurrence and progression via JAK3-STAT6 signaling

TNFAIP6 是一种独立的预后监测指标和治疗靶点,它通过 JAK3-STAT6 信号通路促进低级别胶质瘤的复发和进展。

阅读:1

Abstract

BACKGROUND: Low-grade glioma (LGG, WHO2-3 grade), a kind of common primary tumor of the central nervous system, exhibits high 5-year survival rates but frequently recurs and progresses to higher-grade tumors, leading to poor prognosis. Effective prognostic biomarkers and therapeutic targets are urgently needed. Tumor necrosis factor alpha-induced proteins (TNFAIPs), key regulators within the inflammatory microenvironment, have been proven to play an important role in regulating tumor invasion and metastasis via immunoinflammatory suppression. Nevertheless, their functional mechanism and clinical significance in LGG remained unclear. Lacking studies focused on the direct effects of TNFAIPs themselves on regulating the malignant biological behaviors of LGG. MATERIALS AND METHODS: In this study, we employed bioinformatics analysis, machine learning algorithms, and in vitro cell experiments to investigate the potential effects of TNFAIP6 on LGG. RESULTS: It found that TNFAIP6 can be a reliable prognostic marker for LGG, which directly regulates the malignant behaviors of LGG, including proliferation, invasion, and migration, thereby promoting LGG recurrence and progression. These processes were proven to be closely associated with the activation of the JAK3-STAT6 signaling pathway. CONCLUSION: Our findings demonstrated that TNFAIP6 can directly contribute to the malignant behaviors of LGG, providing a theoretical basis for developing targeted therapeutic strategies against TNFAIP6 and the JAK3-STAT6 signaling axis in LGG.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。